Triple

T22457477
Position Surface form Disambiguated ID Type / Status
Subject ICH Rules of Procedure E555152 entity
Predicate appliesTo P1129 FINISHED
Object International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use | Statement: [ICH Rules of Procedure, appliesTo, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Context triple: [ICH Rules of Procedure, appliesTo, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. International Federation of Pharmaceutical Manufacturers & Associations
    The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global industry body representing research-based biopharmaceutical companies and national associations, advocating for policies that support innovation and access to medicines worldwide.
  • C. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • D. Pharmaceutical Inspection Co-operation Scheme
    The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is an international organization that harmonizes Good Manufacturing Practice (GMP) standards and facilitates cooperation among pharmaceutical regulatory authorities worldwide to ensure the quality and safety of medicines.
  • E. European Federation of Pharmaceutical Industries and Associations
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7d00208190955a70e2c22d25a4 completed April 29, 2026, 1:14 a.m.
Created at: April 16, 2026, 8:48 p.m.